8 March 2021 - A new and potentially curative one-off gene therapy for babies with the rare genetic disorder spinal muscular ...
9 March 2021 - PHARMAC invites proposals for the supply of adalimumab in New Zealand. ...
8 March 2021 - AltruBio announced today that the U.S. FDA granted fast track designation for its immune checkpoint regulator, ...
8 March 2021 - Potential approval in Europe anticipated in early 2022. ...
8 March 2021 - FDA designation will facilitate development and expedited review of company’s lead gene therapy product candidates for ...
8 March 2021 - Men and women tend to respond differently to many kinds of vaccines. That’s probably because of a ...
9 March 2021 - The Australian Government says it wants to build a "coalition of countries" to pressure the European Union ...
8 March 2021 - A medicine known as the most expensive in the world has been approved to treat a rare ...
8 March 2021 - Medicines which can be used to treat a rare genetic disease in children and some cancer ...
8 March 2021 - Approval based on significant progression-free survival findings from Phase 3 KEYNOTE-177 trial. ...
6 March 2021 - The President of the Pacific Pharmacists’Association, Kasey Brown, says a review of New Zealand’s drug buying ...
8 March 2021 - Milestone reinforces Viatris' commitment to complex products and innovative solutions to help increase patient access ...
8 March 2021 - RMAT designation granted by FDA during bleeding disorders awareness month. ...
7 March 2021 - Genentech today announced that the company is voluntarily withdrawing the U.S. indication for Tecentriq (atezolizumab) in prior-platinum ...
8 March 2021 - FDA has set Prescription Drug User Fee Act target action date of 23 August 2021. ...